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Highlights  
In a rat model of Parkinsonism:  
• Upregulation of SK2 channel expression in the subthalamic nucleus  
• Decrease of SK3 channel expression level in the substantia nigra pars compacta 
 
Behavioral performance in a reaction time task of 6-OHDA-lesioned rat 
• Impairment by SK channel blockade with apamin in the subthalamic nucleus 
• Improvement by SK channel blockade with apamin in the substantia nigra pars compacta 
 
Abbreviations: 
 
6-OHDA, 6-hydroxydopamine 
apa, apamin 
BG, basal ganglia  
CoI, cytochrome oxidase subunit I 
CyPPA, N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine 
DA, dopamine  
DAT, dopamine transporter 
ISH, in situ hybridization 
KATP :ATP-sensitive potassium channels 
PD, Parkinson’s disease  
qRT-PCR, quantitative real time polymerase chain reaction 
RT, reaction time task 
SK channels, small-conductance calcium-activated potassium channels 
SNC, substantia nigra pars compacta 
SNR, substantia nigra pars reticulata 
SSC, Saline Sodium Citrate 
STN, subthalamic nucleus 
TH, tyrosine hydroxylase 
VTA, ventral tegmental area 
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Abstract 
Parkinson’s disease (PD) is a progressive neurodegenerative disease originating from the loss of 
dopamine (DA) neurons in the substantia nigra pars compacta (SNC). The small-conductance 
calcium-activated potassium (SK) channels play an essential role in the regulation of midbrain DA 
neuron activity patterns, as well as excitability of other types of neurons of the basal ganglia. We 
therefore questioned whether the SK channel expression in the basal ganglia is modified in 
parkinsonian rats and how this could impact behavioral performance in a reaction time task. We 
used a rat model of early PD in which the progressive nigrostriatal DA degeneration was produced 
by bilateral infusions of 6-hydroxydopamine (6-OHDA) into the striatum. In situ hybridization of 
SK2 and SK3 mRNA and binding of iodinated apamin (SK2/SK3 blocker) were performed at 1, 8 or 
21 days postsurgery in sham and 6-OHDA lesion groups. A significant decrease of SK3 channel 
expression was found in the SNC of lesioned animals at the three time points, with no change of 
SK2 channel expression. Interestingly, an upregulation of SK2 mRNA and apamin binding was 
found in the subthalamic nucleus (STN) at 21 days postlesion. These results were confirmed using 
quantitative real time polymerase chain reaction (qRT-PCR) approach. Functionally, the local 
infusion of apamin into the STN of parkinsonian rats enhanced the akinetic deficits produced by 
nigrostriatal DA lesions in a reaction time task while apamin infusion into the SNC had an opposite 
effect. These effects disappear when the positive modulator of SK channels (CyPPA) is co-
administered with apamin. These findings suggest that an upregulation of SK2 channels in the STN 
may underlie the physiological adjustment to increased subthalamic excitability following partial 
DA denervation.  
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1. Introduction 
 
Variation of potassium (K) channel function and expression has recently been related to the 
abnormal firing of basal ganglia (BG) neurons which is thought to contribute to the expression of 
Parkinson’s disease (PD) (Liu et al., 2010; Surmeier et al., 2007; Wang et al., 2008). K channels, by 
mediating diverse cellular signaling, are critical determinants of neuronal excitability and 
neurotransmitter release (Adelman et al., 2012; Pongs, 2008). In the BG, they contribute to 
maintain basal levels of dopamine (DA) in projection areas by modulating the tonic, low frequency 
action potentials of dopaminergic neurons. Brief transitions to a burst firing mode result in 
barrages of high frequency action potentials that transiently elevate DA levels to trigger DA-
mediated behaviors (Chergui et al., 1994; Schultz, 2002). In animal models of Parkinsonism, 
variation of gene expression of voltage-gated calcium (Kv), ATP-sensitive (KATP) or small 
conductance calcium-activated (SK) K channels is found in structures of the BG known to be 
dysregulated in pathophysiological condition. For example, KATP expression is upregulated in the 
striatum and the subthalamic nucleus (STN) after DA neurons degeneration in the substantia nigra 
pars compacta (SNC) in experimental Parkinsonism (Shen and Johnson, 2012; Wang et al., 2005), 
and in the SNC of Parkinsonian patients (Schiemann et al., 2012). KATP channel opening agents 
injected into the globus pallidus restore locomotor activity in the reserpine-treated rat model of 
Parkinson’s disease and decrease overactive GABA transmission (Maneuf et al., 1996). In addition, 
intraperitoneal injection of ATP channel opener partially alleviates haloperidol-induced catalepsy, 
a rat model of akinesia (Maneuf et al., 1996; Wang et al., 2005). A decrease of Kv4 channel-
dependent IA current is found after striatal DA depletion that contributes to the enhancement of 
striatal medium spiny neurons excitability (Azdad et al., 2009; Day et al., 2006). In vivo, we 
recently demonstrated that local blockade of Kv4 channels in the striatum may reduce the motor 
and neuropsychiatric impairment of partially DA depleted rats (Aidi-Knani et al., 2015).  
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Among K channels, SK channels play an essential role in the intrinsic properties of BG neurons and 
particularly in regulating dopaminergic neurons (Pedarzani and Stocker, 2008). They produce a 
medium afterhyperpolarization following a single action potential and regulate spike frequency 
adaptation, the frequency and precision of pacemaker activity of DA neurons. They also regulate 
action potential firing of striatal GABAergic and subthalamic glutamatergic neurons (Deignan et al., 
2012; Hallworth et al., 2003; Hopf et al., 2010; Wolfart et al., 2001). BG neurons contain SK 
channels made up of either SK2 or SK3 subunits, that are sensitive (albeit differentially) to apamin 
(Sailer et al., 2004). Blockade of SK channels by apamin was recently found to decrease the motor 
and cognitive impairment induced by nigrostriatal DA depletion (Alvarez-Fischer et al., 2013; Chen 
et al., 2014). Interestingly, in vitro SK channel activation by NS309 protects human DA neurons 
submitted to a calcium-dependent neuronal death by inhibiting the mitochondrial complex I with 
rotenone (Dolga et al., 2014), while SK channel blockade with apamin increases DA neurons 
survival in mesencephalic cell culture (Salthun-Lassalle et al., 2004). 
The aim of the present study was to determinate the potential variation of SK channel subunit 
expression during the development of the nigrostriatal DA degeneration. Here, we found an 
increase of SK2 channel expression in the STN after partial 6-OHDA-induced nigrostriatal lesions in 
rats. Moreover, we analyzed the impact of intracerebral activation or blockade of SK channels in 
the SNC and the STN on DA lesion-induced impairment of reaction time (RT) performance for 
which the activation of the STN is essential (Baunez et al., 1995).  
 
2. Materials and methods 
 
2.1. Animals and surgery 
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Male Wistar rats (280-300 g) (Charles River Laboratories, l’Arbresle, France) were housed 2/cage 
and kept at a constant temperature (22 °C) under a 12 h/12 h light/dark cycle (lights on at 7:00 
a.m.). For in situ hybridization (ISH), binding (n=48) and qRT-PCR experiments (n=21), animals 
were given food and water ad libitum. Each animal was handled (10 min) for four days before the 
start of experiments. For behavioral experiments (e.g.  reaction time (RT) task), male Wistar rats (n 
=80) weighing 175–185 g at the beginning of the experiment, were fed 15-17 g/day laboratory 
chow delivered 3 h after the testing period, so as to maintain 85% of their free feeding body 
weight. Water was provided ad libitum. Animal experimental procedures were in strict accordance 
with the recommendations of the European Communities Council Directive (2010/63/EU) and 
conformed to the ethical guidelines of the French National Ethical Committee (authorization # 
A7/12/12). All efforts were made to minimize the numbers of animals used and to maintain them 
in good general health. 
 
2.2. Nigrostriatal 6-OHDA lesions 
 
Animals were anesthetized with a subcutaneously injection (0.33 mL/Kg) of a combination of 
medetomidine (1 mg/mL; Janssen) and ketamine (5%; Virbac, France) and placed in a stereotaxic 
apparatus (David Kopf instrument, Tujunga, CA, USA) with the incisor bar positioned 3.3 mm under 
the interaural line. 6-OHDA hydrobromide (12 μg/3μL per side; Tocris Bioscience, Bristol, U.K.) or 
vehicle (0.1% ascorbic acid in 0.9% NaCl) was bilaterally injected in the striatum at the following 
coordinates (Paxinos and Watson, 2007): AP + 0.2 mm, L ± 3.5 mm, DV – 4.8 mm according to 
bregma as described previously (Lopez et al., 2012). The flow rate (0.33 μL/min) and volume of 
injections were controlled with a micropump (CMA/100; CMA/Microdialysis, Stockholm, Sweden) 
using a 10 μL Hamilton microsyringe connected by a catheter (Tygon®, i.d. 0.25 mm) fitting to the 
30 gauge stainless steel injector needles. Three additional minutes were allowed for diffusion of 
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the toxin. Animals were allowed a 7-d recovery period prior to behavioral testing in the RT task. In 
situ hybridization studies and binding experiments were performed 1, 8 or 21 days after 6-OHDA 
lesions, according to previous studies (Blandini et al., 2007).  
 
 
2.3. Drug treatment 
 
Apamin (Genepep, Montpellier, France) and N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-
methyl-4-pyrimidinamine (CyPPA, Sigma-Aldrich, St Louis, MO, USA) were injected intracerebrally  
in the STN or SN. Rats received bilateral injections of apamin (0.05 or 0.1 ng per side, dissolved in a 
volume of 0.5 µL, in 0.9% sterile NaCl, CyPPA (0.5 µg per side, dissolved in Chremophor® RH 40 
(10%) containing ethanol (4%)) or co-injection of apamin+CyPPA. Doses were chosen on the basis 
of previous reports (Maurice et al., 2015; Mpari et al., 2008). 
 
2.4. Tissue preparation 
  
For in situ hybridization and binding experiments, rats were anesthetized with pentobarbital sodic 
(6%, Sanofi santé, France) and their brain removed after decapitation at different postlesion time-
points (e.g. on day 1, 8 or 21). Brains were immediately frozen on powered dry ice and stored (- 
80°C) until cryostat sectioning. Coronal sections (20 µm for apamin and mazindol binding, 12 µm 
for ISH, and 16 µm for TH immunohistochemistry) were collected (− 20°C) onto on Superfrost Plus 
slides, at level of the striatum, entopeduncular nucleus, STN and SN using a cryostat apparatus 
(model CM3050; Leica, Wetzlar, Germany) and stored at – 80°C. Experiments were carried out 
blind; the group that the rats belonged to was unknown to the person conducting binding and ISH 
experiments. 
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For qRT-PCR, collection of SN and STN samples was adapted from Manrique et al. (2009). Animals 
were sedated with isoflurane (AErrane, Baxter, Belgium) and brains rapidly removed. The SN and 
STN were micro-dissected from 2 mm-thick sections, using a specific slicer at -20°C. Inside 
sections, a cylinder (1 mm diameter) was dissected using a micropunch allowing to obtain cylindric 
samples of 1.6 mm
3
 following the landmarks of the stereotaxic atlas Paxinos and Watson (2007): 
SN, AP - 5.0 mm, L ± 2.0 mm, DV − 8.2 mm; STN, AP - 3.8 mm, L ± 2.4 mm, DV − 8.4 mm according 
to bregma. Tissue specimens were placed in RNase-free microcentrifuge tubes, immediately 
frozen on dry ice and then stored at -80°C. Each hemispheric SN were separately collected and 
analyzed whereas each hemispheric STN were pooled for the analysis.  
 
2.5. Extent of 6-OHDA lesions  
 
 The extent of the lesions was verified by tyrosine hydroxylase immunohistochemistry of DA 
neurons at nigral level and by autoradiographic labelling of DA uptake sites with [
3
H]-mazindol at 
striatal level for DA projection in bilateral 6-OHDA-lesioned groups.  
 
2.5.1. TH immunohistochemistry 
Frozen sections were post-fixated with ice-cold 4% paraformaldehyde in 0.0.5M Tris buffer (pH 
7.4). Following rinsing and preincubation in 0.0.5M Tris solution containing bovine serum albumin 
(BSA, 10%), for 1h, sections were exposed to monoclonal mouse anti-TH (1:3000; IgG, Millipore, 
USA), 1h at room temperature then overnight, 4°C. Sections were then exposed for 2 h, at room 
temperature, to biotinylated goat anti-mouse (1/200, Vector, Burlingame, CA, USA, 1h, room 
temperature), followed by diaminobenzidine visualization method (Elite ABC Kit, Vector), 
dehydrated in ethanol and xylene, and coverslipped using DePex. Between each incubation, the 
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sections were washed several times in 0.05 M Tris buffer with BSA 2%. In control experiments 
where the primary or secondary antibody was omitted, no labelling was observed.  
 
2.5.2.  [3H]-mazindol binding 
Binding of [
3
H]-mazindol was measured according to the procedure described previously (Breysse 
et al., 2002; Chen et al., 2014). In brief, sections were first air-dried and rinsed for 5 min at 4°C in 
50 mM Tris buffer with 120 mM NaCl and 5 mM KCl. Then, the sections were incubated for 40 min 
with 15 nM [
3
H]-mazindol (PerkinElmer, Boston, MA, USA; specific activity: 722 GBq/mmol) in 50 
mM Tris buffer containing 300 mM NaCl and 5 mM KCl added with 0.3 mM desipramine to block 
the noradrenaline transporter. Sections were rinsed twice for 3 min in the incubation medium 
without mazindol, once for 10 s in distilled water and were then air-dried. Finally the sections 
were left in contact for 50 days to a specific Kodak BioMax MR [
3
H]--sensitive film screen to 
generate autoradiograms. Cresyl-violet staining of sections was used to locate the trace of the 6-
OHDA injector needle. 
 
2.6. SK expression  
 
In order to investigate variations of SK expression after bilateral 6-OHDA lesions, we used [
125
I]-
apamin binding for protein expression and ISH with radiolabeled probes of SK α-subunit probes, 
associated with qRT-PCR, for SK2 and SK3 mRNA gene levels. For each autoradiographic 
experiment, brain sections were collected at the level of four brain regions (striatum and globus 
pallidus, entopeduncular nucleus, subthalamic nucleus, and midbrain regions) of six groups (sham 
or 6-OHDA-lesioned groups at three time-points: 1, 8 and 21 days postlesion, n=8 per group). 
Then, to prevent experimental artifacts during analysis of the autoradiograms, the sections of each 
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region were submitted to the same apamin binding or ISH experiment and exposed side by side on 
the same autoradiographic film at each time point.  
 
 
 
2.6.1.  [125I]-apamin binding 
For binding experiments, tissue sections were incubated with highly radioactive apamin labeled 
with [
125
I] (PerkinElmer, NEN Life Science Products, Boston, MA, USA) as previously described 
(Mourre et al., 1986). Brain sections were incubated with 25 pM [
125
I]-apamin (specific activity, 
81.4 TBq/mmol), at 4 °C in 100 mM Tris-Cl buffer, containing 0.5% bovine serum albumin (BSA), pH 
7.4. Nonspecific binding was assessed by adding a large excess of native apamin (0.1 µM, Sigma-
Aldrich, St Louis, MO, USA), before adding [
125
I]-apamin. Sections were incubated for 60 min and 
rinsed three times, each for 20 s, in the same buffer. The sections were rinsed a fourth time, for 20 
s, in water. Dried sections were placed on Kodak BioMax MR Films. Serial sections of one naive rat 
were added with experimental sections, serving as internal standards for labeling at the different 
time-points. Autoradiograms were exposed for 12 days to obtain unsaturated labeling and thus to 
allow the detection of increases or decreases in labeling. Films were then processed in a Kodak 
Industrex developer. Cresyl violet stained sections were used for reference and to locate the trace 
of the 6-OHDA injection and cannula implantations.  
 
2.6.2. In situ hybridization of SK mRNA 
2.6.2.1. Oligonucleotide probes. Oligodeoxynucleotide probes for the rat SK2 α-subunits were 
purchased from Eurogentec S.A. (Angers, France) and purified by reverse phase chromatography. 
Oligodeoxynucleotide probes (45 mers) corresponding to 5' regions for each SK subunit were as 
follows: 5’-AGC-GCC-AGG-TTG-TTA-GAA-TTG-TTG-TGC-TCC-GGC-TTA-GAC-ACC-ACG-3’ (SK2), 5’-
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CGA-TGA-GCA-GGG-GCA-GGG-AAT-TGA-AGC-TGG-CTG-TGA-GGT-GCT-CCA-3’ (SK3), identical to 
those used in a previous study (Stocker et al., 1999; Stocker and Pedarzani, 2000). The probes 
targeted a coding region of the SK α-subunit mRNA at nucleotide residues 233-189 (SK2) and 
2036-1992 (SK3) of the published cDNA sequence (Köhler et al., 1996). The sense 
oligodeoxynucleotide was used as a negative control. Probe specificity was determined with the 
public domain program “BLAST”. The sequences did not display any significant similarity with 
other sequences in the databases. Probe cDNA fragments were prepared by labeling the cDNA 
fragment by the random primer method with [
35
S]-αS-dATP (48.1 TBq/mmol) using a DNA-tailing 
kit (PerkinElmer Inc, NEN Life Science Products, Boston, MA, USA) and terminal deoxynucleotide 
transferase (Roche Diagnostics, Meylan, France). The radiolabeled probes were then purified by 
gel-filtration chromatography and centrifugation (Quick Spin Columns, Roche). Radiolabeled 
probes were then stored at a specific activity (at least 1x10
6
 cpm/µl) at 4°C.  
 
2.6.2.2. In situ hybridization procedures. All solutions were treated with diethylpyrocarbonate and 
autoclaved to avoid RNase degradation. Slide-mounted sections were postfixed at 4°C for 5 min in 
4% paraformaldehyde and were rinsed twice, for 5 min in a phosphate saline buffer (pH 7.2). The 
sections were then acetylated for 10 min with 0.25% acetic anhydride in 0.1 M triethanolamine 
(pH 8) and dehydrated in ethanol. After chloroform treatment, the sections were dried in a 
dessicator. Each section was covered with the DNA labeled probe (5 x 10
5
 cpm/section) diluted in 
35 µl of hybridization solution (4 x Saline Sodium Citrate (SSC) containing 50% formamide, 10% 
dextran sulfate, 1 x Denhardt's solution, 5 mg/mL E. coli tRNA and 2.5 mg/mL sheared salmon 
sperm DNA), and incubated for 12 h at 47 °C for SK2 probes or at 44°C for SK3 probes in humid 
chambers. Afterwards, sections were rinsed in cold 2 x SSC, then in 1 x SSC at room temperature 
for 10 min, 1 x SSC for 30 min at 55°C, with one further wash in 1 x SSC at room temperature, and 
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a final wash in 0.1 x SSC at room temperature. Sections were dehydrated with a graded ethanol 
series and air-dried. Slides were exposed to Kodak Bio-Max MR-1 film for 15 days in the presence 
of [
14
C] plastic standards (Amersham, UK). The exposure times were adjusted to avoid film 
saturation and to obtain labeling of intermediate intensity to quantify changes. Kodak BioMax MR 
Films were developed with Kodak GBX solution for 3 min at 20 °C, rinsed, and fixed.  Cresyl violet 
stained sections were used for reference. 
 
2.6.3. Quantitative real time polymerase chain reaction 
2.6.3.1. Primer design. In order to investigate potential variations of SK2, SK3 gene expression 
levels, 21 days following bilateral 6-OHDA lesions, we used YWHAZ as our reference gene. The 
YWHAZ gene encodes for the tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein zeta polypeptide. YWHAZ is a reference gene recently tested for its stability (Langnaese et 
al., 2008; Nelissen et al, 2010). To ascertain the nigral DA cell loss, the expression level of the 
dopamine transporter dopamine transporter (DAT) gene was also included in the study. Primers 
used in this study were either designed with PRIMER 5 software or the same as those designed by 
Langnaese et al. (2008) and Nelissen et al. (2010). Primer oligonucleotides were purchased from 
Eurogentec (Angers, France). The sequences of the primers are listed in Table S1. 
 
2.6.3.2. Total RNA isolation and cDNA synthesis. Total RNA was isolated from the SN and STN using 
Tri-Reagent (Sigma-Aldrich, St Louis, MO, USA) according to the manufacturer’s recommendations 
and dissolved in 20 µL of nuclease-free water. The concentration of total RNA was determined by 
measuring the optical density at 260 nm (SmartSpec™ 3000 Spectrophotometer, Bio-Rad 
Laboratories, Marnes-la-Coquette, France) and the purity was checked as the 260 nm/280 nm 
ratio with expected values between 1.8 and 2.0. The integrity of total RNA was assessed by 
electrophoresis on 1.2% (w/v) agarose gels. To remove potential DNA contamination, RNA 
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samples were DNase Treated (DNA-Free™, Ambion, Thermo Fisher Scientific, Illkirch, France). 300 
ng of RNA were subjected to reverse transcription using iScript™ cDNA Synthesis Kit (Bio-Rad 
Laboratories, Marnes-la-Coquette, France). The product was then diluted with RNase-free water 
to a cDNA concentration of 50 ng/µL. 
 
2.6.3.3. Quantitative Real time polymerase chain reaction. Relative expression of SK2, SK3 and DAT 
genes in the SN and the STN was carried out by qRT-PCR analyses using the MiniOpticon™ System 
(Bio-Rad Laboratories, France) in 25 µL reactions containing 300 nM of the gene specific primers 
for SK2, SK3, DAT and YWHAZ, 2 µL of cDNA template in a master mix (iQ SYBR Green Supermix, 
Bio-Rad Laboratories, Marnes-la-Coquette, France). After an initial denaturation step at 95°C for 3 
min, amplifications were performed with 40 cycles of 10 s at 95°C/30 s at 50°C. For each sample, 
SYBR Green qRT-PCR was conducted in triplicate and melting curves were included to ascertain the 
formation of a single product from each gene. “No template controls”, in which no cDNA template 
is added, were also performed for each mix prepared. Primer efficiencies were determined by a 
standard curve of samples according to the MIQE guidelines for qRT-PCR (Bustin et al., 2009). Data 
were evaluated with the MiniOpticon CFX Manager™ v2.0 software (Bio-Rad Laboratories, 
Marnes-la-Coquette, France) by the delta-delta CT method that measures the expression level of 
the target gene normalized to the reference gene YWHAZ and relative to the expression of the 
target gene in a calibrate sample (sham). 
 
2.7. Reaction Time task procedure 
Eight operant boxes (Campden Instruments, Cambridge, UK) were used for the reaction time (RT) 
task. Each box was equipped with a retractable lever, a food magazine and a cue light (2.8 W bulb) 
located above the lever corresponding to the response signal. The lever required a force of 0.7 N 
for switch closure. A house light located on the ceiling was turned on at the beginning of the 
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testing session. Each box was placed in a wooden sound-attenuating cabinet that was ventilated 
by a low-level noise fan in order to reduce outside noise. Food restriction was introduced at the 
beginning of the training period. Rats were trained daily for 3 months to quickly release the lever 
after the visual cue onset presented after four randomly and equiprobably generated foreperiods 
(0.5, 0.75, 1.0, or 1.25 s) to be rewarded by a 45 mg food pellet (P.J. Noyes Company, Inc., 
Lancaster, NA, USA). Performance was measured by recording the number of correct and incorrect 
(non-rewarded) responses either “premature,” corresponding to early withdrawal of the lever 
(before the onset of the response signal), or “delayed,” when the lever was released after the 600 
ms time limit. Each daily session ended after 100 trials. Premature responses were recorded 
independently and were not limited. At the end of training period, rats were tested for 5 
consecutive days in the RT task to measure preoperative baseline values before lesion.  
All the animals were then subjected to the 6-OHDA lesion procedure as described above. During 
the same surgery, they were also implanted with 10 mm bilateral stainless steel guide cannulas 
(23 gauge) positioned 3 mm above the injection site in the STN or the SNC at the following 
coordinates: STN: (AP) -3.8 mm, (L) ± 2.4 mm and (DV) -5.4 mm according to bregma; SNC: (AP) -
5.0 mm, (L) ±2.0 mm and (DV) –5.2 mm according to bregma. The guide cannulas were then 
anchored to the skull with four stainless steel screws and dental cement. Stainless steel wire inlet 
cannulas (10 mm) were placed inside to prevent occlusion. After an 8-day recovery period, 
postoperative performance was recorded daily for 30 days. Sham (n = 35) and 6-OHDA (n = 45) 
animals were divided into subgroups receiving intracerebral injection of vehicle, apamin (0.1 or 0.2 
ng), CyPPA (1 µg) and apamin + CyPPA solutions into the STN or the SNC at postsurgical days 16, 
20, 24 and 28. Bilateral intrasubthalamic or intranigral injections of apamin or CyPPA, were 
performed with stainless steel injector needles (13 mm, 30 gauge) inserted inside the implanted 
guide cannulas and fitted so that they protruded 3 mm below, into the STN or the SN area. The 
sites of injection in the STN and SNC are illustrated in Figure S1. Before each testing day, the 
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animals were gently maintained while inserting the injectors into the bilateral implanted guide 
cannulas. Injectors were connected via a polyethylene catheter (Tygon®, i.d. 0.25 mm) to Hamilton 
microsyringes (10 µL) fitted to a micropump (CMA/100, Stockholm, Sweden). The flow delivered 
by the pump was set at 0.16 µL/min for a volume of 0.5 µL/side. At the end of injection, injector 
needles were left in place for 3 more min. to allow the diffusion of the solution. Immediately 
afterwards, inlet cannulas were replaced and the performance in the RT task was recorded. 
 
2.8. Data analysis 
 
2.8.1. TH immunohistochemistry 
Quantification of TH immunostaining was performed by digitized image analysis of the nigral 
sections via computer-assisted image analysis using a Leitz Aristoplan light microscope (Leica 
Microsystems, Wetzlar, Germany) equipped with a DXM 1200 Nikon high-resolution digital camera 
(1024 x1024 pixels; Nikon, Tokyo, Japan) interfaced to a PC computer employing image software 
for capturing and processing the images (Lucia G, Nikon, Champigny-sur-Marne, France). The 
recorded images were further used for estimation of the number of individual TH-immunoreactive 
cell. Using Image J 1.36b imaging software (NIH, Bethesda, MD, USA), after a delimitation of SNC 
nucleus, the total area of this nucleus was assessed as a pixel number in each side of sections at 
four consecutive levels, spending the rostra-caudal extent of the nucleus (from – 4.7 to −5.9 mm 
with respect to the bregma).  Then, only TH immunoreactive cells with visible nuclei were taken 
into account. Survival DA neuron values, expressed as number of TH-positive cells by section and 
averaged for each rat, were analyzed independently by two experimenters blind to the treatment 
groups. In addition, cell counts were performed on Cresyl violet-stained neurons in the SNC and 
the ventral tegmental area (VTA) on alternate sections. 
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2.8.2. [3H]-mazindol binding 
The extent of bilateral nigrostriatal 6-OHDA lesions was estimated by delimitating the lesioned 
area in each hemisphere as the sum of pixels with low gray levels at least five rostro-caudal striatal 
levels per animal (from 2.3 to – 1.6 mm according to the bregma). The level of the lesion was 
determined as the ratio between the lesioned and total striatum areas, expressed as the 
percentage of the total striatal surface assessed as a pixel number. As no difference was found in 
either the surface measured on each side of the brain, the values obtained were averaged. Then, a 
mean ± standard error of the mean (S.E.M.) was calculated for each experimental group. 
 
2.8.3. [125I]-apamin binding 
Autoradiograms were analyzed and radioactivity quantified with NIH Image software. [
14
C] Plastic 
standards were used to calibrate [
125
I] concentrations. Mean receptor density was calculated for 
each nucleus, using six to eight bilateral measurements in each animal. The group value presented 
for each structure studied is the mean of values obtained for each animal ± S.E.M. Non-specific 
binding was detected on autoradiograms of sections incubated with unlabeled 0.1µM apamin, 
corresponding to around 15% of total binding. Specific binding was calculated as the difference 
between total and non-specific binding for a given area. Rat brain regions were identified and 
named using a rat brain atlas (Paxinos and Watson, 2007). 
 
2.8.4. SK2 and SK3 mRNA in situ hybridization 
Film autoradiograms were scanned and hybridization signal quantified using NIH image software; 
the observer was blind to the conditions of the experiment. The gray areas corresponding to 
mRNA labeling were quantified using [
14
C] plastic standards to calibrate [
35
S] relative 
concentration. mRNA labeling was expressed in relative units. Mean value ± S.E.M. was calculated 
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for each brain structure in each hemisphere, using three unilateral measurements in each animal. 
We observed non-specific hybridization in negative control sections (sense probe), i.e. these 
sections displayed a weak, uniform labeling pattern, which did not follow neuroanatomical 
landmarks.  
 
 
 
2.8.5. Reaction time task 
The effects of dopamine depletion and drug injections on RT performance were evaluated on the 
number of correct and incorrect responses (delayed responses) averaged across each session. For 
pre- and postoperative conditions, we averaged the performance measured during 5 consecutive 
sessions before (pre) and after surgery (post). Because there was no difference between the five 
sessions either in the "pre" or the "post" conditions for any variable, the performance was thus 
compared with that measured after apamin, CyPPA or vehicle injection into the STN or the SN.  
 
2.9. Statistical analysis 
 
Using Graphpad Prism6 software, the effects of 6-OHDA lesions on expression were tested by 
means of one-way analysis of variance (ANOVA) or two-way ANOVA, followed by adapted post-
hoc tests between groups (Tukey or Holm-Sidak test). Student’s t test was used to analyze the 
effects of 6-OHDA compared to sham groups injected with vehicle. The paired t-test was used to 
analyze and to compare the expression level of SK2, SK3 and DAT genes. Simple-regression 
analysis was used to identify correlations between 6-OHDA lesions or TH immunoreactivity levels 
and changes in mRNA level. The effect of drug treatment on behavioral performances were 
submitted to two-way ANOVA with groups (sham vs 6-OHDA) as the between-subject factor, and 
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conditions (pre, post, vehicle, apamin or CyPPA) as the within-subject factor, followed by post-hoc 
multiple comparisons test (Holm-Sidak test) as appropriate. All data were expressed as the mean ± 
S.E.M. and a P value of <0.05 was taken as the minimum level of significance. 
 
 
 
3. Results 
 
3.1. Evaluation of 6-OHDA lesions extent 
The lesion extent in the SNC and striatum was analyzed at three time-points (1, 8, and 21 days 
postlesion).  The decrease of TH-positive cells was found along the whole rostro-caudal axis (Fig. 
1A). No significant difference was found between the number of TH-positive cells in the SNC of the 
left and right side of the brain, therefore the data were pooled per rat. In the SNC, the group x 
time ANOVA revealed a significant interaction (F2,41=4.22, P < 0.05) and a main effect of lesion 
(F1,41=72.83, P < 0.01) and no time effects (F2,41=2.33, NS) (Fig. 1B). Compared to sham groups, 
Tukey test showed that the number of TH-positive cells was significantly reduced by 19.5 ± 0.72% 
at days 1 and 8 (P < 0.05) and by 37% at day 21 following 6-OHDA lesions (P < 0.05). The decrease 
at day 21 was significantly different from that observed on day 1 (P < 0.05).  No significant change 
was found in the VTA (data not shown). Bilateral infusion of 6-OHDA in the striatum produced a 
loss of DA nerve terminals restricted to its dorsal part, extending to the rostro-caudal axis of the 
striatum, as shown by decreased [
3
H] mazindol binding to dopamine uptake sites, expressed as 
percentage of lesioned area, by 33.6 ± 1.72% compared with sham animals whatever the studied 
time-points (Fig. 1C and 1D). These data are consistent with the decrease of endogenous striatal 
DA contents assessed by HPLC (Amalric et al., 1995). No difference was found between the levels 
of mazindol binding in the striatum at the three time-points after 6-OHDA lesions (F2,21=0.67, NS). 
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Regression analysis revealed a negative correlation between the levels of mazindol binding and 
the number of TH-positive cells of 6-OHDA-lesioned rats at 21 days postlesion only (P < 0.05) (Fig. 
1E) (e.g. the lowest TH-positive cell density, the more extensive lesioned striatal area). Moreover, 
qRT-PCR was used to investigate the changes of mRNA expression of DAT in 6-OHDA-lesioned and 
sham groups at 21 days postlesion. Dopamine transporter (DAT) RNA expression in the SNC was 
significantly reduced to 36.62 ± 5.17% in 6-OHDA-lesioned animals when compared with sham 
animals. 
 
 
3.2. Variations of SK channel protein and SK mRNA expression following 6-OHDA lesions 
 
3.2.1. Apamin binding 
As previously reported (Mourre et al., 1986; Mpari et al., 2008), [
125
I]-apamin binding sites that 
correspond to SK2 and SK3 channels, were unevenly distributed in the rat brain (Fig. 2, Table 1). In 
the basal ganglia, apamin binding sites were found at high levels in the SNC. The density of apamin 
binding sites in the STN, striatum, and thalamus was intermediate and low in the globus pallidus.  
In the SNC, a two-way ANOVA revealed an effect of postlesion time (F2,41= 8.98, P < 0.01) and of 
lesion (F1,41=5.24, P < 0.05) but no significant interaction (F2,41=2.63, P=0.08) on the apamin 
binding site level. A Tukey test showed that 6-OHDA infusion significantly reduced apamin binding 
compared to that of vehicle infusion (-12%) at 21 days postlesion (P < 0.05) (Fig. 3A) but not at 1 
and 8 days postlesion (Table 1). At this time-point, apamin binding in the SNC of 6-OHDA-lesioned 
group was also lower than that at 8 days postlesion (P < 0.05)(Table 1). A well-defined correlation 
was found between the TH-immunoreactivity density in the SNC and the apamin binding level at 
21 days postlesion (P=0.02) (Fig. 3A).  
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In the STN, an increase of apamin binding (+14%) was detected in the 6-OHDA-lesioned group 
compared to sham group, at 21 days postlesion only (Table1, Fig 4A). Indeed, data analysis 
revealed a lesion (F1,41=5.70, P < 0.05) and postlesion time effect (F2,41= 8.17, P < 0.01) with no 
lesion x time interaction (F2,41=0.36, NS). Variations of SK channel protein amount in the STN were 
related to the DA neuronal degeneration in the SNC. A negative correlation between apamin 
binding level in the STN and TH immunoreactivity density of the SNC was found (P < 0.01) (Fig. 4A). 
When the number of TH-positive cells was low in the SNC, apamin binding was high in the STN. No 
significant interaction, lesion or postlesion time effect was found between 6-OHDA-lesioned and 
sham groups for the dorsal and ventral striatum, entopeduncular nucleus, globus pallidus, 
substantia nigra pars reticulata and VTA (two-way ANOVA, F2,41≤3.32, NS; F1,41≤3.51 NS; F2,41≤2.92, 
NS, respectively)(Table 1). 
 
3.2.2.  SK2 mRNA expression  
In situ hybridization labeling of SK2 mRNA was found at intermediate to low levels in the BG nuclei 
including the SNC and STN (Fig. 2, Table 1). As previously observed for SK channel protein, no 
difference in the levels of SK2 mRNA was found at the two first time-points following 6-OHDA 
lesions compared to sham groups and regardless of the structure (Table 1). At 21 days postlesion, 
no difference of SK2 mRNA levels was found either in the SNC (Fig. 3B), the SNR, striatum, 
entopeduncular nucleus or the VTA (Table 1). In contrast, in the STN, there was a significant 
variation of SK2 mRNA expression of 6-OHDA-lesioned animals, as revealed by a postlesion days x 
group interaction (F2,41= 6.21, P < 0.01). At 21 days postlesion, a significant increase (+18%) of SK2 
mRNA expression in the STN of 6-OHDA-lesioned group was found when compared to the sham 
group (Fig. 4B, Table 1) and to 6-OHDA-lesioned groups at the two other time points (Tukey test, P 
< 0.05). Linear regression showed a correlation between SK2 mRNA levels in the STN and TH 
immunoreactivity density of the SNC (P = 0.004, Fig. 4B). No such correlation was observed with 
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SK2 mRNA levels in the SNC (Fig. 3B). The increase of SK2 mRNA expression in the STN was related 
to the decreased TH-positive cells in the SNC. Moreover, qRT-PCR analyses confirmed the 
enhancement of SK2 expression level in the STN of 6-OHDA-lesioned group by 45% (Fig. 4D) 
compared to sham group while no difference was found in the SN (Fig. 3D). Linear regression 
showed a negative relationship between nigral DAT and SK2 expression levels in the STN (Fig 4D). 
 
 
3.2.3. SK3 mRNA expression 
High levels of SK3 mRNA expression were found in the SNC and VTA and low to intermediate 
densities in the other structures of the BG (Fig. 2). No significant difference was detected between 
in situ hybridization labelling of SK3 mRNA in the studied brain structures of 6-OHDA-lesioned and 
sham groups at 1, 8, and 21 days postlesion except for the SNC and VTA (Table 1).  
In the SNC, a two-way ANOVA revealed a main effect of lesion (F1,41=48.59, P < 0.001) and of 
postlesion time (F2,41= 4.36, P < 0.05) but not interaction (F2,41= 1.23, NS). Whatever the postlesion 
time-points, SK3 mRNA levels in this structure were lower in the 6-OHDA-lesioned groups 
compared to sham groups (-29, -24, -41% at 1, 8, 21 days respectively) (Tukey test, P < 0.05) (Fig. 
3C and S2, Table 1). SK3 mRNA level was positively related to TH-positive cell density in the SNC. 
The lower the TH-positive cell density, the higher decrease of SK3 mRNA expression level was 
observed (P < 0.05) (Fig. 3C and S2). These results were confirmed by qRT-PCR analyses at 21 days 
postlesion. SK3 mRNA expression level in the SN of 6-OHDA-lesioned group significantly decreased 
by 43% compared to sham group (t test, P < 0.05) (Fig. 3D). Moreover, this reduction was 
positively correlated with that of DAT levels (P < 0.05).  
At 21 days postlesion, a 21% decrease of SK3 mRNA expression was also found at the level of the 
VTA, with a trend already observed at days 1 and 8. A main effect of lesion (F1,40=11.5, P < 0.01) 
and postlesion time effect (F1,40=9.30, P < 0.01) but no interaction (F2,40= 0.58, NS) were found 
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(Table 1). No variation of SK3 expression was found in the STN whatever the postlesion time 
(Table1, Fig. 4C). 
 
3.3. Modulation of SK channel activity on Parkinsonian symptoms 
 
The behavioral effects of the partial bilateral 6-OHDA lesions were examined by testing the 
performance of rats previously trained for several months to release a lever after the presentation 
of a visual cue with rapid RTs, for food reinforcement (Amalric et al., 1995). While performance of 
sham-operated groups was unchanged after lesion, an increase in the number of incorrect 
responses (e.g. delayed response over the time limit of 600 ms) was observed in the different 
lesioned groups as early as 8 days after the lesion. This effect lasted for over 30 days postlesion 
and was significantly different from preoperative or sham levels of performance (Fig. 5). The 
ANOVA revealed a significant main effect of group, SN group 1 (apa dose-response): F1,17=12.86 
and group 2 (apa+CyPPa) F1,12=6.20 and STN: F1,27=10.19, P < 0.05). Lengthening of RTs was also 
observed (pre: 310-330 ms to post: 360-380 ms, data not shown). Similar disruption of RTs was 
previously measured in parkinsonian patients tested in simple RT tasks (Evarts et al., 1981) 
indicative of the akinetic symptoms of the disease. Premature responses (responses before the 
visual cue onset) were not modified by the lesion. 
 
3.3.1. Effect of SK channel modulation in the substantia nigra on reaction time performance 
We first tested the effects of SK channel blockade with different doses of apamin directly injected 
in the SNC on RT performance of lesioned and sham animals (illustrated in Fig. S3). The animals 
with injection sites located above or below the SNC were discarded from statistical analyses. 
Apamin 0.1 or 0.2 ng did not modify RT performance of sham animals. As previously found, an 
increase of the number of delayed responses was produced by partial 6-OHDA nigrostriatal lesions 
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(Baunez et al. 1995). Apamin at a dose of 0.1 ng failed to attenuate the deficits induced by the 
lesions as the number of delayed responses remained significantly higher than in sham animals 
(Holm-Sidak test, P < 0.05 after a significant main group effect, ANOVA, F1,18=12.48 (P < 0.05) 
(Fig. S3). At a dose of 0.2 ng, however, apamin dramatically reduced the number of delayed 
responses that was no longer different from the level of the sham group. The reduction was close 
to significantly different from postoperative levels (P = 0.05, Holm-Sidak test, Fig. S3). 
Interestingly, in a few animals (n=4) where the injection sites were located ventrally in the SNR, 
apamin had no effect on RT performance (data not shown). In a second group of animals, we 
further tested the effects of apamin 0.2 ng injections in the SNC on behavioral performance and 
challenged these animals with the SK channel positive modulator, CyPPA at a dose of 1 µg (Fig. 
5A). As previously found, apamin 0.2 ng reduced the number of delayed responses induced by the 
6-OHDA lesions which reached 22 % of the total responses after surgery or after local NaCl 
injection (significant difference between 6-OHDA-lesioned and sham groups, P < 0.05 Holm-Sidak 
test, after significant main group effect F1,12=24.07, Fig. 5A).  Activation of SK channels with CyPPA 
in the SNC of sham or 6-OHDA-lesioned animals had no effect on its own. When jointly 
administered with apamin 0.2 ng, however, CyPPA tended to counteract the antiakinetic action of 
apamin. 
 
3.3.2. Effect of SK channel modulation in the subthalamic nucleus on reaction time performance  
SK channel blockade with apamin (0.1 ng) or activation with CyPPA (1.0 µg), either separately or 
conjointly injected in the STN, significantly disrupted RT performance of 6-OHDA-lesioned subjects 
when compared with sham-operated subjects (Fig. 5B). The overall ANOVA revealed a main group 
effect (F1,27=33.30, P < 0.01), a main treatment effect (F4,108=2.95, P < 0.05) and close to significant 
group x treatment interaction (F4,108=2.36, P=0.05). The increased number of delayed responses 
produced by bilateral striatal 6-OHDA lesions was further enhanced by 29.5 % by apamin 
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treatment in comparison to NaCl injection (Holm-Sidak test, P < 0.05). In contrast, activation of SK 
channels with CyPPA reduced the number of delayed responses produced by the lesion and no 
more difference was observed with sham animals injected with the same dose of CyPPA (Holm-
Sidak test, NS). Likewise, no significant effect of single or joint apamin and CyPPA treatment was 
found in sham-operated animals. Interestingly, the deleterious effect on RT performance 
produced by SK channel blockade was reduced when CyPPA was jointly administered with apamin. 
Although this effect did not reach significant level in comparison to apamin single treatment (e.g. 
the subjects were still unable to release the lever in due time like lesioned animals injected with 
vehicle), the lower impairment indicates that SK channels activation might counteract apamin-
induced effect. To verify if repeated intra-cerebral injections could modify RT performance over 
time, we conducted a new set of experiments with a group of 6-OHDA-lesioned animals and shams 
that received only the respective vehicle injections of apamin and CyPPA at the same 
postoperative days. There was no significant difference of vehicle injections on behavioral 
performance of the two groups over time (Fig. S4).  
 
4. Discussion 
 
In rats with a partial nigrostriatal DA denervation, a significant decrease of SK3 channel expression 
level is found in the substantia nigra pars compacta (SNC) with no change in SK2 channel 
expression. At 21 days postlesion, an upregulation of SK2 mRNA expression and apamin binding 
sites is found in the subthalamic nucleus (STN). Behavioral studies show that the blockade of 
SK2/SK3 channels with apamin infusion into the STN of parkinsonian rats enhances the deficits 
produced by nigrostriatal DA lesions in the reaction time task, while apamin in the SNC has 
opposite effects on RT performance. These effects disappear when the positive modulator of SK 
channels CyPPA is co-administered with apamin.  
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4.1. Partial nigrostriatal degeneration modulates SK channels expression in the basal ganglia 
 
The motor symptoms of Parkinson’s disease classically emerge when 58–64% of the SNC 
dopaminergic neurons have degenerated (McGeer et al., 1988). In rodents, mimicking a relatively 
early stage of PD is particularly challenging in view of the disabling cognitive and affective 
symptoms occurring during the premotor phase of the disease (Chaudhuri et al., 2011). In our rat 
model of PD based on bilateral intrastriatal infusion of the catecholamine neurotoxin 6-OHDA in 
the striatum, a restricted loss of tyrosine hydroxylase (TH)-positive neurons (19 %) occur as early 
as one day postlesion and gradually increase over time to 37 %. Interestingly, the reduction of 
DAergic fibers in the striatum is occurring at the same time and the loss of around 35 % of DA 
uptake sites is circumscribed to the dorsal part of the striatum that is maintained for up to 21 days 
postlesion. The reduction of TH-positive fibers and DA levels in the striatum follows a similar time-
course in earlier studies following bilateral (Amalric et al., 1995; Bonito-Oliva et al., 2014; 
Tadaiesky et al., 2008) or unilateral intrastriatal 6-OHDA infusions (Blandini et al., 2007; Rosenblad 
et al., 2000; Stott and Barker, 2014). This partial and progressive loss of nigral TH-positive neurons, 
although not similar to the human pathology, may help to detect early changes in the disease at 
cellular and behavioral levels. 
Here we confirm that SK2 and SK3 channel subunits are present in the basal ganglia nuclei with 
different densities of mRNA expression and channel protein (Sailer et al., 2004; Stocker and 
Pedarzani, 2000) and that apamin binding levels are correlated with the distribution of SK channel 
protein (Mourre et al., 1986; Sailer et al., 2004). A regional differentiation in the basal ganglia of 
sham control animals is found with high density of SK3 channels in the SNC and SK2 channels in 
the STN, with intermediate to low density in the other structures. Interestingly, the main effect 
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produced by partial 6-OHDA dopaminergic lesion is to induce opposite changes of apamin binding 
sites, SK2 and SK3 channel expression in the SNC and the STN.  
 
4.2. Decrease of SK channel expression in the substantia nigra 
 
In the substantia nigra, nigrostriatal 6-OHDA lesions reduced the expression of apamin binding 
sites and SK3 channels. The decrease of SK3 channel subunits expression is correlated to the 
progressive loss of DA neurons at the three postlesion time points. There was no alteration of SK2 
channel expression at the histological resolution used here. SK3 is highly enriched in DA neurons 
with high density on the soma and dendrites (Wolfart et al., 2001), which explains the progressive 
loss of SK3 channel expression produced by the dopaminergic nigrostriatal lesions. SK2 channels 
may also be expressed at very low densities and only on distal dendrites of DA neurons (Deignan 
et al., 2012) and more extensively in the SNR. The decrease of SK3 mRNA expression measured at 
1 and 8 days postlesion (29 and 24% respectively) is not observed at the channel protein level as 
the apamin binding site is only significantly reduced at 21 days postlesion. Apamin binds with a 
higher affinity for SK2 than for SK3 channels (Finlayson et al., 2001; Grunnet et al., 2001). Others 
have found that the affinity of apamin for SK2 and SK3 is actually the same, but the ability of 
apamin to block SK2 is higher (Lamy et al., 2010). This might hide a potential decrease of channel 
protein at an earlier time-point.  
We recently demonstrated that apamin given intraperitoneally between 15 to 25 days after similar 
striatal 6-OHDA infusions could counteract the motor and nonmotor symptoms (anxiety, 
anhedonia and visuospatial memory deficits) induced by partial dopaminergic striatal depletion 
(Chen et al., 2014). Apamin also increased extracellular DA concentration in the striatum of 6-
OHDA-lesioned rats (Chen et al., 2014). The present results show that apamin directly injected in 
the SNC at a dose of 0.2 ng reduces the akinetic symptoms in the reaction time task produced by 
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6-OHDA lesions. Interestingly, the SK channel positive modulator, CyPPA, while having no effect on 
its own, is able to counteract apamin action on RT performance when jointly administered with 
apamin into the SNC. SK3 channels appear to be specifically involved in this process as partial 6-
OHDA lesions only modulate SK3 channels mRNA expression and not SK2 channels. SK3 channels 
are known to control the timing and stability of the endogenous pacemaker activity of DA neurons 
in the SNC and VTA (Seutin et al., 1993; Wolfart et al., 2001) and to promote bursting  in vivo 
(Waroux et al., 2005). Apamin administration increases DA neurotransmission in the nucleus 
accumbens (Herrik et al., 2012; Steketee and Kalivas, 1990). Altogether, these findings suggest 
that the blockade of SK channels in the spared midbrain DA neurons could compensate for the loss 
of DA activity in the dorsal striatum.  Consistent with this hypothesis, the suppression of the 
endogenous SK currents in DA neurons by the expression of a mutant form of the human SK3 
gene, increases burst firing by reducing the coupling between SK channels and N-methyl-D-
aspartate (NMDA) receptors, and ultimately enhances DA release (Soden et al., 2013).  
 
4.3. Upregulation of SK2 channels in the subthalamic nucleus 
 
In the subthalamic nucleus, 6-OHDA lesions of the nigrostriatal DA pathway produced a significant 
increase of SK2 mRNA expression and apamin binding sites that is correlated to the loss of TH-
positive cells at 21 days postlesion with no change at days 1 or 8. SK3 mRNA expression was not 
modified at any time postlesion. The upregulation of SK2 channel expression in the STN is 
observed when a significant percentage of DA neurons degenerate in the SNC (37 %). Whether this 
upregulation is more pronounced over time when the DA neuronal degeneration progresses 
further still remains to be determined. Recent studies showed that 6-OHDA lesions induce an 
increase of firing rate, failures in autonomous activity, and pronounced burst activity in the STN 
(Park et al., 2015; Remple et al., 2011; Wilson et al., 2006; Zhu et al., 2002). A loss of around 40% 
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of TH-positive DA neurons is associated with an enhancement of bursting activity and change of 
STN neuronal firing pattern (Breit et al., 2007; Janssen et al., 2012; Park et al., 2015) consistent 
with data from Parkinsonian patients (Remple et al., 2011). The delayed onset of SK2 channel 
overexpression after 6-OHDA lesions of nigrostriatal DA neurons does not parallel the rapid 
disruption of DA transmission but rather correlates with homeostatic plasticity allowing neurons 
to compensate for perturbations in PD and chronic animal models (Azdad et al., 2009; Surmeier et 
al., 2007; Zigmond et al., 1990). In models of PD, variations of K channels expression are already 
considered as forms of homeostatic adaptation. Indeed, upregulation of KATP channels, in the 
prefrontal cortex and striatum, is found to serve as a protective mechanism after unilateral 6-
OHDA lesions of the SNC (Shen and Johnson, 2012; Wang et al., 2005). Inversely, decrease of a Kv4 
channel-dependent KIA current in the striatal medium spiny neurons compensates for the 
reduction in glutamatergic efficiency after DA depletion (Azdad et al., 2009; Day et al., 2008, 
2006). We previously showed that partial 6-OHDA lesions of nigrostriatal DA pathway leads to a 
dramatic increase in gene expression of the metabolic marker cytochrome oxidase subunit I (CoI) 
mRNA in the STN (Oueslati et al., 2005). Abnormal activation of the STN may thus occur early in 
the course of the disease when striatal DA depletion is moderate as found here. Compared to 
previous data showing no or slight increase in CoI mRNA expression in the STN after extensive 
striatal denervation (Vila et al., 2000), this suggests that STN reactivity may be even more 
pronounced at early than at later stages of the disease.  
Consistent with this suggestion, apamin, when injected directly into the STN, dramatically 
enhances the akinetic symptoms in rats performing the RT task, presumably by enhancing 
subthalamic neuronal activity. Indeed, in vitro, addition of apamin on STN slices does not modify 
single-spike activity but increases irregular spike intervals and neuronal excitability (Hallworth et 
al., 2003; Wilson et al., 2004). These functional changes may explain the exacerbated deficits 
observed here. In contrast to apamin-induced effects, activating SK channels in the STN with the 
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positive modulator CyPPA tended to reduce the motor impairment produced by 6-OHDA lesions. 
In vitro, activation of SK channels increases the amount and duration of single-spike 
afterhyperpolarization, which leads to a decrease in the frequency of autonomous rhythm. We 
may thus postulate that CyPPA could reverse the motor deficits produced by 6-OHDA lesions by 
decreasing the activity of STN neurons as previously found after STN lesions (Baunez et al., 1995). 
This remains to be investigated by recording subthalamic neurons in behaving animals.  
 
The STN plays a central role in the response of the basal ganglia to cortical and thalamic activation 
during movement (Bevan et al., 2006). Taken together, these findings suggest that the variations 
of SK channels expression could reflect compensatory mechanisms occurring early in the 
progression of cellular defects in PD. The modulation of SK channels by activating SK2 subunits 
and/or blocking SK3 subunits with selective new compounds could thus be proposed as alternative 
therapeutic targets for the treatment of patients with Parkinson’s disease.  
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Captions 
 
Figure 1  
Evaluation of 6-OHDA lesion extent. A: Tyrosine hydroxylase (TH) immunohistochemistry. 
Representative illustrations of TH immunostaining in the substantia nigra pars compacta (SNC) at 
21 days after a bilateral intrastriatal injection of 6-hydroxydopamine (6-OHDA, n=1) or vehicle 
(sham, n=1). A substantial loss of TH-immunoreactive cells was observed at different rostro-caudal 
levels of the SNC (-5.04 to -5.76 mm according to bregma) in a 6-OHDA-lesioned rat. SNR, 
substantia nigra pars reticulata; VTA, ventral tegmental area. Scale bar: 500 µm. B: Number of TH-
positive cells by coronal section at different rostro-caudal levels in the SNC of 6-OHDA-lesioned 
animals at 1, 8 or 21 days postlesion (n= 8, 7 and 8, respectively) compared with sham animals (n= 
8, 8 and 8, respectively).  Data are expressed as mean ± S.E.M., ANOVA, * P < 0.05 compared to 
sham groups, # P<0.05 compared to 6-OHDA-lesioned groups. C: Mazindol binding. Illustrative 
autoradiographs of [
3
H]-mazindol binding to dopamine uptake sites in the striatum at different 
rostro-caudal levels (1.68 to -1.44 according to bregma), at 21 days after bilateral 6-OHDA lesions. 
In the caudate putamen (CPu), the lesioned area was defined by a loss of dopamine uptake 
binding sites (in light gray) compared to the intact area (dark gray). There was no loss of mazindol 
binding in the accumbens nucleus (Acb). Scale bar: 3 mm. D: Mazindol binding site levels in the 
striatum expressed as the ratio of the lesioned area over the total striatal area (n=8/group). E: 
Correlation between the number of TH-positive cells by sections in the SNC and the mazindol 
binding levels. Simple-linear regression analyses. Each dot represents data of one subject. Dotted 
lines correspond to the 95% confidence of regression line. Note the negative correlation between 
mazindol binding sites levels in the lesioned area and the number of TH-positive cells by sections 
in the SNC. 
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Figure 2 
Expression of SK channels in the rat substantia nigra and subthalamic nucleus of sham and 6-
OHDA-lesioned rats at 21 days postlesion. A: Histological reconstructions of sections, indicating 
the location of the substantia nigra, pars compacta (SNC) (left) and of the subthalamic nucleus 
(STN) (right), adapted from Paxinos and Watson (2007). B: Representative distribution of apamin 
binding sites; Coronal brain sections were incubated with [
125
I]-apamin (25 pM). The dark areas 
indicated high staining intensity, corresponding to a high density of binding sites. Note that 
apamin binding sites decreased in SNC and increased in STN, 21 days after the 6-OHDA lesions; In 
situ hybridization of SK2 mRNA (C) or SK3 mRNA (D). SK2 and SK3 mRNA signals were revealed by 
autoradiographic in situ hybridization using a specific antisense probe labeled with [
35
S]. Note that 
SK3 mRNA expression were reduced in the SNC and SK2 mRNA expression enhanced in the STN 21 
days after 6-OHDA lesions. Bar = 1 mm. 
 
Figure 3  
Expression of SK channels in the substantia nigra, pars compacta at 21 days postlesion. Left: (A) 
Levels of apamin binding sites in sham (n = 8) and 6-OHDA-lesioned groups (n=8). (B) ISH, levels of 
SK2 mRNA. (C) ISH, levels of SK3 mRNA. (D) qRT-PCR, quantitative mRNA expression for the three 
genes encoding the SK2 and SK3 subunits and the dopamine transporter (DAT) in 6-OHDA-lesioned 
group (n = 11, bar graphs) in comparison to sham group (n = 10, dotted line). Note the decrease of 
apamin binding level and of SK3 mRNA expression level in 6-OHDA-lesioned group. Right: 
Correlation between the number of TH-positive cells in the SNC and the apamin binding site 
density or SK channel mRNA levels. Simple-linear regression analysis. Each dot corresponds to the 
data of one 6-OHDA-lesioned subject. Dotted lines correspond to the 95% confidence of 
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regression line. Note the positive direction of correlation for apamin binding sites and SK3 mRNA 
levels but not with SK2 mRNA levels. The SK3 channel expression decreased in correlation with 
dopamine degeneration since SK2 channels expression did not differ. Data expressed as mean ± 
S.E.M. * P < 0.05, statistical significance between sham and 6-OHDA groups. 
 
Figure 4  
 
Expression of SK channels in the subthalamic nucleus at 21 days postlesion. Left: (A) Levels of 
apamin binding sites in sham (n = 8) and 6-OHDA-lesioned groups (n=8). (B) ISH, levels of SK2 
mRNA. (C) ISH, levels of SK3 mRNA. (D) qRT-PCR, quantitative mRNA expression for the three 
genes encoding the SK2 and SK3 subunits and the dopamine transporter (DAT) in 6-OHDA-lesioned 
group (n = 11, bar graphs) in comparison to sham group (n = 10, dotted line). Note the increase of 
apamin binding level and of SK2 mRNA expression in 6-OHDA-lesioned group. Right: Correlation 
between the number of TH-positive cells in the SNC and the apamin binding site density or SK 
channel mRNA levels. Simple-linear regression analysis. Each dot corresponds to the data of one 6-
OHDA-lesioned subject. Dotted lines correspond to the 95% confidence of regression line. Note 
the negative correlation for apamin binding sites and SK2 mRNA levels but not with SK3 mRNA 
levels. The SK2 channel expression increased with dopamine degeneration since SK3 channels 
expression did not differ. Data expressed as mean ± S.E.M. * P < 0.05, statistical significance 
between sham and 6-OHDA groups. 
 
 
Figure 5 
Behavioral effects of the SK channel modulation in 6-OHDA-lesioned animals on reaction time 
performance. Performance is expressed by the mean number of incorrect responses (delayed 
response over the time limit of 600 ms) ± S.E.M. SK channel blockade or activation was performed 
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respectively by apamin or CyPPa infusion in the substantia nigra (SN) (A) or in the subthalamic 
nucleus (STN) (B) of sham (n = 7 and 13 respectively, open bars) and of 6-OHDA-lesioned (n = 7 
and 16 respectively, black bars) groups. Note the increase of incorrect responses after lesion in the 
6-OHDA groups compared to sham groups. Apamin (0.2 ng) infusion in the SNC of 6-OHDA-
lesioned groups reduced the akinetic deficit that was counteracted by a simultaneous infusion of 
the SK channel positive modulator (CyPPa, 0.1 µg). Inversely, apamin (0.1 ng) infusion in the STN of 
6-OHDA-lesioned groups increased the number of incorrect responses while CyPPa (0.1 µg) 
administration reduced the akinetic deficit. ANOVA, * P < 0.05 compared to sham groups, # P<0.05 
compared to vehicle-injected 6-OHDA group. 
 
Supplemental data 
 
Table S1: Gene-specific primers used for qRT-PCR 
 
Figure S1  
Representations of the placements of the injector needles in the substantia nigra and subthalamic 
nucleus. Photomicrographs of one representative section from two subjects depicting bilateral 
cannula tracks (arrows) with tips located in the substantia nigra, pars compacta (SNC) or in the 
subthalamic nucleus (STN). Dashed lines mark the SNC, SNR (substantia nigra, pars reticulata), and 
cp (cerebral peduncle) on the left, and the STN and cp on the right. (B) Frontal sections of brain 
showing histological reconstruction of injection sites in the SNC (n=12) and STN (n=19). Values give 
the distance in mm from bregma according to the atlas of Paxinos and Watson (2007). Bar = 2 mm. 
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Figure S2 
Expression of SK3 channels in the substantia nigra, pars compacta at 1 (A) and 8 (B) days 
postlesion. Left: Levels of SK3 mRNA. Note the decrease of apamin binding level and of SK3 mRNA 
density in 6-OHDA-lesioned group. Right: Correlation between the number of TH-positive cells in 
the SNC and SK3 channel mRNA levels. Simple-linear regression analysis. Each point corresponded 
to the data of one 6-OHDA-lesioned rat. Dotted lines correspond to the 95% confidence of 
regression line. Note the positive correlation for apamin binding sites and SK3 mRNA levels. Data 
expressed as mean ± S.E.M. * P < 0.05, statistical significance between sham and 6-OHDA groups. 
 
Figure S3 
Behavioral effects of SK channel blockade with apamin injected in the substantia nigra of sham  
(n = 8) and 6-OHDA-lesioned (n = 12) animals on reaction time performance. Performance is 
expressed by the mean number of incorrect responses (delayed response over the time limit of 
600 ms) ± S.E.M.. Note the increase of incorrect responses after lesion in the 6-OHDA-lesioned 
groups compared to sham groups. Apamin at a dose of 0.2ng but not at 0.1ng reduced the number 
of delayed responses to reach the level of performance of sham groups. ANOVA, * P < 0.05 
compared to sham groups. 
 
Figure S4 
Behavioral effects of the vehicle injections at the same postoperative days than apamin or CyPPa 
administration on reaction time performance. Performance is expressed by the mean number of 
incorrect responses (delayed response over the time limit of 600 ms) ± S.E.M. in the sham (n = 7) 
and 6-OHDA-lesioned (n = 6) groups. There was no significant difference on behavioral 
performance of the two groups over time.  
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D1
Caudate putamen 229.83 ± 1.90 222.91 ± 4.55 39.84 ± 1.82 44.86 ± 1.98 56.69 ± 9.47 74.48 ± 7.24
Accumbens nucleus 270.34 ± 4.16 289.72 ± 5.55 38.02 ± 3.63 42.95 ± 1.86 101.74 ± 7.23 100.57 ± 7.18
Globus pallidus 118.96 ± 8.87 119.18 ± 6.59 31.00 ± 2.35 32.39 ± 2.37 42.47 ± 5.73 39.30 ± 3.85
Entopeduncular nucleus 89.76 ± 5.63 89.65 ± 5.01 36.38 ± 1.43 39.41 ± 2.54 84.57 ± 3.95 75.32 ± 4.57
Subthalamic nucleus 131.88 ± 4.88 140.28 ± 5.31 109.58 ± 3.81 105.86 ± 5.62 40.59 ± 1.38 42.29 ± 2.16
Substantia nigra, pars compacta 186.36 ± 8.41 181.22 ± 7.01 88.39 ± 5.05 92.66 ± 5.66 151.76 ± 6.02 108.49 ± 5.67*
Substantia nigra, pars reticulata 150.03 ± 7.96 145.74 ± 5.99 45.60 ± 4.47 49.64 ± 4.45 43.96 ± 4.17 33.26 ± 2.46
Ventral tegmental area 171.11 ± 7.37 176.80 ± 8.87 82.16 ± 8.92 93.74 ± 8.97 104.87 ± 9.73 84.44 ± 4.20
D8
Caudate putamen 239.11 ± 6.59 243.36 ± 2.14 42.01 ± 4.44 46.34 ± 4.87 73.11 ± 6.88 70.74 ± 5.77
Accumbens nucleus 287.14 ± 3.71 285.28 ± 5.03 43.64 ± 5.54 39.88 ± 4.09 93.60 ± 7.13 107.96 ± 8.97
Globus pallidus 111.74 ± 5.32 115.92 ± 4.09 27.77 ± 1.65 28.99 ± 1.28 43.10 ± 5.95 37.57 ± 2.80
Entopeduncular nucleus 97.94 ± 4.19 100.34 ± 4.78 39.63 ± 3.59 36.47 ± 2.58 82.13 ± 4.39 76.00 ± 5.74
Subthalamic nucleus 120.27 ± 11.77 135.64 ± 7.69 117.88 ± 7.75 109.60 ± 4.21 45.68 ± 2.53 41.55 ± 5.16
Substantia nigra, pars compacta 201.66 ± 6.82 198.94 ± 3.24 99.08 ± 5.78 84.70 ± 5.94 141.67 ± 4.61 107.82 ± 8.19*
Substantia nigra, pars reticulata 161.76 ± 5.16 166.55 ± 3.57 52.19 ± 2.90 51.29 ± 5.82 35.92 ± 2.20 34.43 ± 2.77
Ventral tegmental area 177.34 ± 3.71 179.11 ± 3.55 87.25 ± 6.09 85.04 ± 11.54 100.79 ± 5.87 88.44 ± 5.83
D21
Caudate putamen 237.12 ± 4.19 236.69 ± 3.22 42.91 ± 5.02 41.40 ± 5.53 75.57 ± 4.06 75.03 ± 6.56
Accumbens nucleus 279.05 ± 3.39 281.23 ± 2.50 43.61 ± 4.76 46.02 ± 4.49 103.13 ± 6.96 114.52 ± 11.05
Globus pallidus 106.67 ± 4.97 112.60 ± 2.92 30.12 ± 2.11 27.89 ± 1.33 41.08 ± 3.28 38.11 ± 4.21
Entopeduncular nucleus 97.35 ± 4.14 97.47 ± 4.24 37.87 ± 2.39 38.80 ± 3.40 82.13 ± 3.04 70.77 ± 3.73
Subthalamic nucleus 147.40 ± 2.72 168.66 ± 3.06* 112.44 ± 1.43 132.69 ± 2.27* 44.59 ± 3.45 46.49 ± 1.71
Substantia nigra, pars compacta 184.03 ± 3.18 161.78 ± 5.81* 87.21 ± 10.21 78.66 ± 6.88 133.53 ± 9.76 78.83 ± 11.07*
Substantia nigra, pars reticulata 146.84 ± 5.89 156.66 ± 6.13 47.23 ± 5.63 50.02 ± 5.38 38.82 ± 4.15 31.14 ± 3.10
Ventral tegmental area 165.26 ± 9.42 165.81 ± 5.94 82.74 ± 10.38 91.90 ± 4.30 100.07 ± 4.43 78.45 ± 7.19*
Values are mean ± S.E.M.
ANOVA, Tukey post hoc test, * P<0.05
Apamin binding sites SK2 mRNA
Sham 6-OHDA Sham 6-OHDA
SK3 mRNA
Sham 6-OHDA
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